Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.

MLA

Weigand, Isabel, et al. “Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.” The Journal of Clinical Endocrinology and Metabolism, vol. 105, no. 8, Aug. 2020. EBSCOhost, https://doi.org/10.1210/clinem/dgaa293.

APA

Weigand, I., Altieri, B., Lacombe, A. M. F., Basile, V., Kircher, S., Landwehr, L.-S., Schreiner, J., Zerbini, M. C. N., Ronchi, C. L., Megerle, F., Berruti, A., Canu, L., Volante, M., Paiva, I., Della Casa, S., Sbiera, S., Fassnacht, M., Fragoso, M. C. B. V., Terzolo, M., & Kroiss, M. (2020). Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study. The Journal of Clinical Endocrinology and Metabolism, 105(8). https://doi.org/10.1210/clinem/dgaa293

Chicago

Weigand, Isabel, Barbara Altieri, Amanda M F Lacombe, Vittoria Basile, Stefan Kircher, Laura-Sophie Landwehr, Jochen Schreiner, et al. 2020. “Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study.” The Journal of Clinical Endocrinology and Metabolism 105 (8). doi:10.1210/clinem/dgaa293.